home / stock / avhhl / avhhl news

AVHHL News and Press, Avita Therapeutics From 04/13/23

Stock Information
Company Name: Avita Therapeutics
Stock Symbol: AVHHL
Market: OTC
Website: avitamedical.com
Menu
AVHHL AVHHL Quote AVHHL Short AVHHL News AVHHL Articles AVHHL Message Board
Get AVHHL Alerts

News, Short Squeeze, Breakout and More Instantly...
AVHHL - AVITA Medical Announces Update to Automation Device

VALENCIA, Calif. and MELBOURNE, Australia, April 13, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, announced tod...
AVHHL - AVITA Medical Appoints New Non-Executive Member to the Board of Directors

VALENCIA, Calif. and MELBOURNE, Australia, March 16, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, announced tod...

AVHHL - AVITA Medical to Present at the TD Cowen 43rd Annual Health Care Conference

VALENCIA, Calif. and MELBOURNE, Australia, March 02, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, announced tod...

AVHHL - AVITA Medical to Host Investor Webinar Briefing

VALENCIA, Calif. and MELBOURNE, Australia, Feb. 27, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, invites shareh...
AVHHL - AVITA Medical, Inc. (RCEL) Q4 2022 Earnings Call Transcript

AVITA Medical, Inc. (RCEL) Q4 2022 Earnings Conference Call February 23, 2023 04:30 PM ET Company Participants Caroline Corner - Managing Director, Investor Relations Jim Corbett - Chief Executive Officer Sean Ekins - Acting Chief Financial Officer Conference Cal...

AVHHL - AVITA Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Guidance

VALENCIA, Calif. and MELBOURNE, Australia, Feb. 23, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “ Company ”), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies ...

AVHHL - AVITA Medical to Announce Fourth Quarter and Full Year 2022 Financial Results and Provide 2023 Financial Guidance

VALENCIA, Calif. and MELBOURNE, Australia, Feb. 09, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, announced toda...
AVHHL - AVITA Medical Announces Management Changes and Fourth Quarter 2022 Earnings Conference Call

VALENCIA, Calif. and MELBOURNE, Australia, Jan. 19, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical” or the “Company”), a regenerative medicine company leading the development and commercialization of first-in-class devices and aut...

AVHHL - AVITA Medical, Inc. (RCEL) Q3 2022 Earnings Call Transcript

AVITA Medical, Inc. (RCEL) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Caroline Corner - Managing Director, Investor Relations Jim Corbett - Chief Executive Officer Michael Holder - Chief Financial Officer Conference C...

AVHHL - AVITA Medical, Inc. (RCEL) CEO Dr. Mike Perry on Q2 2022 Results - Earnings Call Transcript

AVITA Medical, Inc. (RCEL) Q2 2022 Results Conference Call August 11, 2022 05:00 PM ET Company Participants Caroline Corner - Managing Director, Investor Relations Dr. Mike Perry - Chief Executive Officer Michael Holder - Chief Financial Officer Conference ...
Previous 10 Next 10